82 related articles for article (PubMed ID: 25273131)
21. Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells.
Zhao J; Li R; He J; Shi J; Long L; Li Z
Rheumatol Int; 2008 Nov; 29(1):9-16. PubMed ID: 18600328
[TBL] [Abstract][Full Text] [Related]
22. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.
Garcia G; Komagata Y; Slavin AJ; Maron R; Weiner HL
J Autoimmun; 1999 Nov; 13(3):315-24. PubMed ID: 10550219
[TBL] [Abstract][Full Text] [Related]
23. T cell regulation of collagen-induced arthritis in mice. II. Immunomodulation of arthritis by cytotoxic T cell hybridomas specific for type II collagen.
Chiocchia G; Boissier MC; Manoury B; Fournier C
Eur J Immunol; 1993 Feb; 23(2):327-32. PubMed ID: 8436167
[TBL] [Abstract][Full Text] [Related]
24. The preventive effect of oral administration of type I interferon on collagen-induced arthritis in rats.
Yoshino S
Exp Mol Pathol; 1995 Apr; 62(2):123-30. PubMed ID: 8549696
[TBL] [Abstract][Full Text] [Related]
25. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
26. Superior molecularly altered influenza virus hemagglutinin peptide 308-317 inhibits collagen-induced arthritis by inducing CD4+ Treg cell expansion.
Sun J; Li R; Guo J; Jia Y; Sun X; Liu Y; Li Y; Huang F; Lu L; Li Z
Arthritis Rheum; 2012 Jul; 64(7):2158-68. PubMed ID: 22231228
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
Mauri C; Feldmann M; Williams RO
Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
[TBL] [Abstract][Full Text] [Related]
28. T cell epitopes of type II collagen that regulate murine collagen-induced arthritis.
Myers LK; Seyer JM; Stuart JM; Terato K; David CS; Kang AH
J Immunol; 1993 Jul; 151(1):500-5. PubMed ID: 7686947
[TBL] [Abstract][Full Text] [Related]
29. Reduced susceptibility to collagen-induced arthritis in DBA/1J mice expressing the TSG-6 transgene.
Mindrescu C; Dias AA; Olszewski RJ; Klein MJ; Reis LF; Wisniewski HG
Arthritis Rheum; 2002 Sep; 46(9):2453-64. PubMed ID: 12355494
[TBL] [Abstract][Full Text] [Related]
30. Analysis of autoreactive T cells associated with murine collagen-induced arthritis using peptide-MHC multimers.
Huang JC; Vestberg M; Minguela A; Holmdahl R; Ward ES
Int Immunol; 2004 Feb; 16(2):283-93. PubMed ID: 14734614
[TBL] [Abstract][Full Text] [Related]
31. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
32. A synthetic peptide analogue of a determinant of type II collagen prevents the onset of collagen-induced arthritis.
Myers LK; Rosloniec EF; Seyer JM; Stuart JM; Kang AH
J Immunol; 1993 May; 150(10):4652-8. PubMed ID: 8482852
[TBL] [Abstract][Full Text] [Related]
33. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
Salazar L; Aravena O; Abello P; Escobar A; Contreras-Levicoy J; Rojas-Colonelli N; Catalán D; Aguirre A; Zúñiga R; Pesce B; González C; Cepeda R; Cuchacovich M; Molina MC; Salazar-Onfray F; Delgado M; Toes RE; Aguillón JC
Ann Rheum Dis; 2008 Sep; 67(9):1235-41. PubMed ID: 18056756
[TBL] [Abstract][Full Text] [Related]
34. Immunopathogenesis of collagen arthritis.
Brand DD; Kang AH; Rosloniec EF
Springer Semin Immunopathol; 2003 Aug; 25(1):3-18. PubMed ID: 12904888
[TBL] [Abstract][Full Text] [Related]
35. C57BL/6 mice need MHC class II Aq to develop collagen-induced arthritis dependent on autoreactive T cells.
Bäcklund J; Li C; Jansson E; Carlsen S; Merky P; Nandakumar KS; Haag S; Ytterberg J; Zubarev RA; Holmdahl R
Ann Rheum Dis; 2013 Jul; 72(7):1225-32. PubMed ID: 23041839
[TBL] [Abstract][Full Text] [Related]
36. Reversal of tolerance induced by transplantation of skin expressing the immunodominant T cell epitope of rat type II collagen entitles development of collagen-induced arthritis but not graft rejection.
Bäcklund J; Treschow A; Firan M; Malmström V; Issazadeh-Navikas S; Ward ES; Holmdahl R
Eur J Immunol; 2002 Jun; 32(6):1773-83. PubMed ID: 12115661
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis.
Lorenzo N; Barberá A; Domínguez MC; Torres AM; Hernandez MV; Hernandez I; Gil R; Ancizar J; Garay H; Reyes O; Altruda F; Silengo L; Padrón G
Autoimmunity; 2012 Sep; 45(6):449-59. PubMed ID: 22686732
[TBL] [Abstract][Full Text] [Related]
38. Type II collagen oral tolerance; mechanism and role in collagen-induced arthritis and rheumatoid arthritis.
Park KS; Park MJ; Cho ML; Kwok SK; Ju JH; Ko HJ; Park SH; Kim HY
Mod Rheumatol; 2009; 19(6):581-9. PubMed ID: 19697097
[TBL] [Abstract][Full Text] [Related]
39. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
[TBL] [Abstract][Full Text] [Related]
40. MHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritis.
Huan J; Kaler LJ; Mooney JL; Subramanian S; Hopke C; Vandenbark AA; Rosloniec EF; Burrows GG; Offner H
J Immunol; 2008 Jan; 180(2):1249-57. PubMed ID: 18178865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
